SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004059
Filing Date
2017-05-10
Accepted
2017-05-09 21:37:54
Documents
68
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q depo-20170331x10q.htm 10-Q 2023247
2 EX-10.2 depo-20170331ex1028f1cb5.htm EX-10.2 35626
3 EX-10.3 depo-20170331ex1030e190c.htm EX-10.3 24517
4 EX-10.4 depo-20170331ex104c30a9a.htm EX-10.4 112602
5 EX-31.1 depo-20170331ex311061c14.htm EX-31.1 20498
6 EX-31.2 depo-20170331ex312f5bbbf.htm EX-31.2 21181
7 EX-32.1 depo-20170331ex321a629a6.htm EX-32.1 9120
8 EX-32.2 depo-20170331ex322485537.htm EX-32.2 9632
  Complete submission text file 0001558370-17-004059.txt   8359704

Data Files

Seq Description Document Type Size
9 EX-101.INS depo-20170331.xml EX-101.INS 1851666
10 EX-101.SCH depo-20170331.xsd EX-101.SCH 51601
11 EX-101.CAL depo-20170331_cal.xml EX-101.CAL 78881
12 EX-101.DEF depo-20170331_def.xml EX-101.DEF 228662
13 EX-101.LAB depo-20170331_lab.xml EX-101.LAB 510255
14 EX-101.PRE depo-20170331_pre.xml EX-101.PRE 359491
Mailing Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560 510-744-8000
DEPOMED INC (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 17828294
SIC: 2834 Pharmaceutical Preparations